Crossmark

A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome

Crossref DOI link: https://doi.org/10.1186/s12969-022-00726-2

Published Online: 2022-08-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Devrim, İlker https://orcid.org/0000-0002-6053-8027
Böncüoğlu, Elif https://orcid.org/0000-0002-3521-0484
Kıymet, Elif https://orcid.org/0000-0002-7251-070X
Şahinkaya, Şahika https://orcid.org/0000-0002-5057-9052
Çelebi, Miray Yılmaz https://orcid.org/0000-0002-3537-0664
Cem, Ela https://orcid.org/0000-0002-5401-8367
Düzgöl, Mine https://orcid.org/0000-0002-3190-2950
Arıkan, Kamile Ötiken https://orcid.org/0000-0002-3357-7952
Kara, Aybüke Akaslan https://orcid.org/0000-0002-9212-5155
Besin, Dorukhan https://orcid.org/0000-0002-3481-1755
Vuran, Gamze https://orcid.org/0000-0001-6787-6144
Seven, Pınar https://orcid.org/0000-0001-7305-9984
Meşe, Timur https://orcid.org/0000-0002-4433-3929
Ağın, Hasan https://orcid.org/0000-0003-3306-8899
Bayram, Nuri https://orcid.org/0000-0003-1802-2518
License Information

Text and Data Mining valid from 2022-08-20

Version of Record valid from 2022-08-20
More Information

Article History

Received: 30 November 2021

Accepted: 26 July 2022

First Online: 20 August 2022

Declarations

:

: Approved from local committee of ethics.Written informed consent was obtained from all individual participants included in the study.

: Ilker Devrim had an educational grant from BD and Ilker Devrim has educational webinars for BD. However, all authors have no conflicts of interest about this manuscript.

Document is current

Any future updates will be listed below